New anti-VEGF therapy shows promise in Phase 1 Clinical trial
anti-VEGF

New anti-VEGF therapy shows promise in Phase 1 Clinical trial

The new drug is manufactured by 4D Molecular Therapeutics and is a dual-transgene intravitreal gene therapy.
Port Delivery System therapy looking for FDA approval
age-related macular degeneration

Port Delivery System therapy looking for FDA approval

The new device offers a continuous therapeutic dose of ranibizumab to the eye in place of regular eye injections.
Neovascular Macular Degeneration Patients Can Gain Visual Acuity After Cataract Surgery
anti-VEGF injections

Neovascular Macular Degeneration Patients Can Gain Visual Acuity After Cataract Surgery

Researchers compared the visual outcomes and rate of intraoperative complications in patients with nAMD and control eyes that did not have nAMD that underwent phacoemulsification cataract surgery o...

USA Only, Spend $50, get free shipping

Free shipping is currently available for orders within the United States only.